Exome Asset Management’s Edgewise Therapeutics EWTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.63M	Buy	124,470 +53,032	+74%	+$695K	1.21%	32
2025 Q1	$1.57M	Sell	71,438 -10,035	-12%	-$221K	1.4%	32
2024 Q4	$2.18M	Buy	81,473 +21,573	+36%	+$576K	1.63%	24
2024 Q3	$1.6M	Buy	+59,900	New	+$1.6M	1.08%	40